Table 1.
Clinical characteristics of all study subjects (mean ± s.d.)
| Variable | Subjects (n = 66) |
|---|---|
| Age (years) | 34.3 ± 7.4 |
| Weight (kg) | 83.8 ± 17.6 |
| BMI (kg/m2) | 31.0 ± 6.6 |
| HMW adiponectin (μg/ml) | 3.1 ± 1.6 |
| Total adiponectin (μg/ml) | 5.3 ± 2.1 |
| Total serum cholesterol (mg/dl) | 174.8 ± 37.6 |
| HDL cholesterol (mg/dl) | 49.9 ± 11.3 |
| LDL cholesterol (mg/dl) | 105.9 ± 32.9 |
| Serum triglycerides (mg/dl) | 95.1 ± 52.2 |
| Glucose-AUC (mg/dl × 120 min) | 14,968 ± 2,598 |
| Insulin-AUC (mg/dl × 120 min) | 4,468 ± 2,818 |
| HOMAIR | 1.5 ± 1.0 |
| CT: TAT (cm2) | 479.3 ± 208.0 |
| CT: SAT (cm2) | 388.5 ± 169.5 |
| CT: VAT (cm2) | 90.8 ± 58.0 |
| DXA: total body fat (kg) | 33.3 ± 12.2 |
| DXA: trunk fat (kg) | 15.8 ± 6.9 |
| IMCL-TA/H2O (%) (n = 48) | 0.45 ± 0.26 |
| IMCL-SOL/H2O (%) (n = 48) | 2.2 ± 1.1 |
| IHL/H2O (%) (n = 48) | 5.6 ± 7.3 |
AUC, area under the curve; CT, computed tomography; DXA, dual-energy X-ray absorptiometry; HDL, high-density lipoprotein; HMW, high-molecular weight; HOMAIR, homeostasis model assessment of insulin resistance; IHL, intrahepatic lipids; IMCL, intramyocellular lipids; LDL, low-density lipoprotein; SAT, subcutaneous adipose tissue; SOL, soleus muscle; TA, tibialis anterior muscle; TAT, total abdominal adipose tissue; VAT, visceral adipose tissue.